Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Matador Resources

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance analyst
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analysts have offered a range of opinions on Matador Resources (NYSE: MTDR) in the last quarter, with some being bullish, somewhat bullish, and indifferent. Over the past month, there have been no bullish ratings, one somewhat bullish rating, and no indifferent or bearish ratings. The outlook has shifted from positive to neutral in recent months. The average 12-month price target for Matador Resources is $68.4, with a high estimate of $72.00 and a low estimate of $62.00, representing a 7.57% decrease from the previous average price target of $74.00.

Recent analyst actions have influenced these ratings and price targets. Gabe Daoud from TD Cowen upgraded the rating to Outperform with a price target of $72.00, while Subash Chandra from Benchmark downgraded the rating to Buy with a price target of $62.00. Tim Rezvan from Keybanc raised the rating to Overweight with a price target of $71.00, and John Freeman from Raymond James lowered the rating to Outperform with a price target of $70.00. Nitin Kumar from Mizuho also decreased the rating to Buy with a price target of $67.00.

In the past three months, Matador Resources has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings, with an average analyst price target of $72.00. This data underscores the ever-changing landscape of analyst evaluations and their influence on market perceptions of Matador Resources.

[bs_slider_forecast ticker=”AI”]

AI Stock Price Momentum Decreases on March 4, 2024: Investor Confidence Wanes

On March 4, 2024, AI stock experienced a slight decrease in price momentum. According to data from CNN Money, the price of AI shares dropped $1.10 since the market last closed, representing a 2.98% decrease. In pre-market trading on March 4, AI stock continued to decline, dropping an additional $0.21. This downward trend in price indicates a potential lack of investor confidence in the stock at the moment. Investors should carefully consider all available information before making any investment decisions. It is essential for investors to conduct thorough research and analysis to determine the long-term potential of the stock. It is recommended to consult with a financial advisor before making any investment decisions.

Currently Playing

AI Companies Stock Performance: Revenue Growth vs. Declining Profitability – March 4, 2024 Analysis

On March 4, 2024, the stock performance of AI companies showed a mixed bag of results based on the financial data provided by CNN Money. Total revenue for AI companies was reported at $266.80 million over the past year, with a quarterly revenue of $78.40 million. The total revenue has increased by 5.55% since last year and by 7.06% since the last quarter. This indicates a positive trend in revenue growth for AI companies. However, the net income for AI companies tells a different story. The net income was reported at -$268.84 million over the past year, with a quarterly net income of -$72.63 million. The net income has decreased by 39.97% since last year and by 4.09% since the last quarter. This decline in net income could be a cause for concern for investors. Earnings per share (EPS) for AI companies were reported at -$2.45 over the past year, with a quarterly EPS of -$0.60. The EPS has decreased by 35.35% since last year but increased by 2.5% since the last quarter. While the increase in EPS since the last quarter is a positive sign, the overall decrease in EPS since last year reflects the challenges faced by AI companies in generating profits for their shareholders. Overall, the stock performances of AI companies on March 4, 2024, reflect a mixed picture of revenue growth and declining profitability. Investors should carefully consider these financial indicators before making investment decisions in AI stocks.

[stock_market_chart symbol=”AI” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: AI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Stock Charts (2)

Ares Commercial Real Estate Downgraded to Underperform

Neurotechnology

Apple Unveils New MacBook Air Models with M3 Chip and Impressive Features

Biopharmaceutical

Groundbreaking Results of Nanobody Sonelokimab in Treating Hidradenitis Suppurativa

Recommended

Walgreens Stock

Walgreens Acquisition Clears Final Hurdle with Strong Bondholder Support

1 week ago
EEFT stock news

Anticipated Earnings Release and Stock Performance for Central Puerto NYSE CEPU

1 year ago
Mining Markets and money

Analyst Remains Positive on Sigma Lithiums Potential Despite Lowered Price Target

2 years ago
Healthcare Services Stock Exchange

Dexcom Inc Reports Impressive Financial Results and Promising Outlook for Continuous Glucose Monitoring

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe ADSK Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO Nvidia NVO Opendoor Oracle Palantir PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Analysts Maintain Strong Buy Ratings for Curis Despite Stock’s Steep Decline

Jazz Pharmaceuticals Secures Dual Regulatory Wins for Oncology Drug

Leadership Transition at Simmons First National Amid Major Financial Restructuring

A Tale of Two Technologies: Cummins Navigates AI Boom and Green Transition

Construction Equity Defies Earnings Miss with Record Rally

American Rebel Holdings Faces Nasdaq Delisting Amid Financial Struggles

Trending

Paramount Stock
Market Commentary

Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership

by Robert Sasse
August 31, 2025
0

Paramount Global has embarked on a comprehensive corporate transformation, culminating in a landmark merger and a groundbreaking...

Aldeyra Therapeutics Stock

Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates

August 31, 2025
Semler Scientific Stock

Semler Scientific’s High-Stakes Bitcoin Bet Faces Mounting Pressure

August 31, 2025
Curis Stock

Analysts Maintain Strong Buy Ratings for Curis Despite Stock’s Steep Decline

August 31, 2025
Chimerix Stock

Jazz Pharmaceuticals Secures Dual Regulatory Wins for Oncology Drug

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Paramount’s Strategic Reboot: A New Era with Skydance and UFC Partnership August 31, 2025
  • Aldeyra Therapeutics Achieves Dual Regulatory Milestones for Key Drug Candidates August 31, 2025
  • Semler Scientific’s High-Stakes Bitcoin Bet Faces Mounting Pressure August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com